BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Small Cambridge Biotech Warp Bio Scores $387M R&D Pact With Drug Giant Roche

  Warp Drive Bio inked a strategic collaboration deal with Roche for up to $387M.

  October 16, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Heads Up Biotechs: Illumina Ventures Closes $230M Fund

  The new venture capital fund with a focus on early-stage companies is making waves in the biotech world.

  October 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Incyte Claims Flexus Lured Away CSO and Its IDO Secrets, Then Sold Itself to Bristol-Myers in $1.25B Deal

  Incyte has levelled charges of stealing company secrets against the founders of Flexus Biosciences over the hiring of Incyte’s former CSO who had access to Incyte’s scientific research.

  October 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Cash Woes Lead SoCal’s Orexigen to Seek Merger or Sale of Company

  In a filing with the SEC,Orexigen indicated that it may not have enough funds to continue operating.

  October 16, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Flexion Arthritis Drug Approval Sparks Acquisition Rumors

  The approval has made Flexion an even bigger target of acquisition rumors.

  October 16, 2017

   · 

  2 min read

   · 

  Mark Terry
• Business

  Innovent Licenses Use Of Harbour Biomed’s Biologic Drug Discovery Platform

  Suzhou’s Innovent Biologics will use a proprietary H2L2 transgenic mouse platform owned by Harbour Biomed of Shanghai to discover new mAbs.

  October 16, 2017

   · 

  1 min read
• 

  Drug Development

  Exelixis Shoots Up as Cancer Drug Meets Goals in Phase III Trial

  Cabometyx hit key endpoints of overall survival in its Phase III liver cancer trial and investors are overjoyed.

  October 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Pfizer Touts Mid-Stage Lung Cancer, Brain Tumor Data

  Strong, durable responses seen against lung tumors and brain metastases across multiple lines of therapy.

  October 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Roche Could Take a $500M Hit Over Patent Losses

  Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income.

  October 16, 2017

   · 

  1 min read
• 

  Policy

  Court Declares that Masimo Employees Stole Secrets for Sotera

  A San Diego bankruptcy court issued a final judgement that two former Masimo employees had misappropriated trade secrets, which they turned over to Sotera Wireless.

  October 16, 2017

   · 

  2 min read

   · 

  Mark Terry